Who owns the TRITAC trademark?

The TRITAC trademark is owned by Harpoon Therapeutics, Inc..

What is the serial number for TRITAC?

The USPTO serial number for TRITAC is 87270473.

What is the registration number for TRITAC?

TRITAC is registered under USPTO registration number 5788225.

TRI

USPTO Trademark Record

REGISTERED

TRITAC

Q: What class is the TRITAC trademark registered in?

The TRITAC trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

SN 87270473·Reg 5788225·Filed Dec 15, 2016

Owner Harpoon Therapeutics, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

TRITAC (Serial No. 87270473), Registration No. 5788225, is a registered US trademark filed on Dec 15, 2016 by Harpoon Therapeutics, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

Section 8/9 declaration window: June 25, 2029

Mark Intelligence

TRITAC (Reg. #5788225) is a registered US trademark that has been protecting its owner, Harpoon Therapeutics, Inc., since 2016. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Dec 15, 2016

SERIAL

87270473

REG#

5788225

REGISTERED

Jun 25, 2019

Owner

Applicant

Harpoon Therapeutics, Inc.

Entity

Corporation

State

Address

3260 Bayshore Boulevard, Brisbane, CA, 94005

Country

Attorney

NameLisa M. Dellamura

Law firm

Lisa M. Dellamura Merck & Co., Inc.

Docket

TM2024012US1

Address

126 East Lincoln Avenue, Office of General Counsel, Rahway, NJ 07065, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateDec 15, 2016

Serial Number87270473

Registration No.5788225

Registration DateJun 25, 2019

Status DateMar 17, 2025

Published for OppositionMay 02, 2017

Next RenewalJune 25, 2029

Mark TypeStandard characters

Attorney DocketTM2024012US1

Status DescriptionLive and registered, partial Section 8 and 15 accepted

Filing Signals

FILED

2016

YEARS AGO

10y

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

First use anywhere: Jul 30, 2018

First use in commerce: Jul 30, 2018

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Jul 30, 2018

First use in commerce: Jul 30, 2018

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

46 events

REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Mar 17, 2025

REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Mar 17, 2025

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Mar 08, 2025

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

TEAS SECTION 8 & 15 RECEIVED

Nov 07, 2024

TEAS SECTION 8 & 15 RECEIVED

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Jun 25, 2024

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Apr 17, 2024

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Apr 17, 2024

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Apr 17, 2024

TEAS CHANGE OF CORRESPONDENCE RECEIVED

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Apr 17, 2024

TEAS CHANGE OF OWNER ADDRESS RECEIVED

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Apr 17, 2024

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

REGISTERED-PRINCIPAL REGISTER

Jun 25, 2019

REGISTERED-PRINCIPAL REGISTER

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

May 23, 2019

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

CORRESPONDENCE RECEIVED IN LAW OFFICE

May 22, 2019

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

May 22, 2019

TEAS/EMAIL CORRESPONDENCE ENTERED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

May 22, 2019

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

ASSIGNED TO LIE

May 21, 2019

ASSIGNED TO LIE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

May 14, 2019

TEAS RESPONSE TO OFFICE ACTION RECEIVED

NON-FINAL ACTION E-MAILED

Nov 27, 2018

NON-FINAL ACTION E-MAILED

SU - NON-FINAL ACTION - WRITTEN

Nov 27, 2018

SU - NON-FINAL ACTION - WRITTEN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Nov 27, 2018

NOTIFICATION OF NON-FINAL ACTION E-MAILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Nov 03, 2018

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

STATEMENT OF USE PROCESSING COMPLETE

Nov 02, 2018

STATEMENT OF USE PROCESSING COMPLETE

SOU EXTENSION 3 GRANTED

Nov 02, 2018

SOU EXTENSION 3 GRANTED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Oct 31, 2018

CASE ASSIGNED TO INTENT TO USE PARALEGAL

USE AMENDMENT FILED

Oct 24, 2018

USE AMENDMENT FILED

SOU EXTENSION 3 FILED

Oct 24, 2018

SOU EXTENSION 3 FILED

SOU TEAS EXTENSION RECEIVED

Oct 24, 2018

SOU TEAS EXTENSION RECEIVED

TEAS STATEMENT OF USE RECEIVED

Oct 24, 2018

TEAS STATEMENT OF USE RECEIVED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jun 14, 2018

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 2 FILED

Jun 12, 2018

SOU EXTENSION 2 FILED

SOU EXTENSION 2 GRANTED

Jun 12, 2018

SOU EXTENSION 2 GRANTED

SOU TEAS EXTENSION RECEIVED

Jun 12, 2018

SOU TEAS EXTENSION RECEIVED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Dec 15, 2017

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 1 FILED

Dec 13, 2017

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Dec 13, 2017

SOU EXTENSION 1 GRANTED

SOU TEAS EXTENSION RECEIVED

Dec 13, 2017

SOU TEAS EXTENSION RECEIVED

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Aug 21, 2017

TEAS CHANGE OF OWNER ADDRESS RECEIVED

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Aug 21, 2017

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jun 27, 2017

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

May 02, 2017

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

May 02, 2017

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Apr 12, 2017

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 21, 2017

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Mar 16, 2017

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Dec 21, 2016

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Dec 19, 2016

NEW APPLICATION ENTERED

TRITAC

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by Harpoon Therapeutics, Inc.

Other Marks by Lisa M. Dellamura

Resources

Company